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Summary
C. elegans SIR-2.1, a member of the Sir-2 family of
NAD+-dependent protein deacetylases, has been shown
to regulate nematode aging via the insulin/IGF path-
way transcription factor daf-16. Treatment of C. ele-
gans with the small molecule resveratrol, however,
extends life span in a manner fully dependent upon
sir-2.1, but independent of daf-16. Microarray analysis
of worms treated with resveratrol demonstrates the
transcriptional induction of a family of genes encoding
prion-like glutamine/asparagine-rich proteins involved
in endoplasmic reticulum (ER) stress response to un-
folded proteins. RNA interference of abu-11, a member
of this ER stress gene family, abolishes resveratrol-
mediated life span extension, and overexpression of
abu-11 extends the life span of transgenic animals.
Furthermore, SIR-2.1 normally represses transcrip-
tion of abu-11 and other ER stress gene family mem-
bers, indicating that resveratrol extends life span by
inhibiting sir-2.1-mediated repression of ER stress
genes. Our findings demonstrate that abu-11 and
other members of its ER stress gene family are posi-
tive determinants of C. elegans life span.
Introduction
Numerous genes have been identified that regulate the
life span of model organisms (Braeckman et al., 2001;
Guarente and Kenyon, 2000; Hekimi and Guarente,
2003; Kenyon, 2005), including genes that encode Sir2
proteins (Blander and Guarente, 2004), components of
the insulin/IGF signaling pathway (Friedman and John-
son, 1988; Kenyon et al., 1993; Kimura et al., 1997), and
heat shock proteins (Nollen and Morimoto, 2002; Wu,
1995). Certain heat shock proteins and the heat shock
transcription factor have been shown to be longevity
determinants in D. melanogaster (Morrow et al., 2004;
Tatar et al., 1997) and C. elegans (Hsu et al., 2003; Lith-
gow et al., 1995; Morley and Morimoto, 2004), perhaps
by counteracting the presence of misfolded proteins in
the cytoplasm and nucleus arising from oxidative or
other types of protein damage.
SIR2 and its orthologs represent a conserved group
of genes encoding NAD+-dependent protein deacety-
lases (Imai et al., 2000; Landry et al., 2000; North and
Verdin, 2004) that are responsive to metabolic changes*Correspondence: leng@mit.eduin the cellular environment, including nutrient/energy
availability and cellular stress (Lin and Guarente, 2003).
Increased dosage of Sir2 homologs from S. cerevisiae
(Kaeberlein et al., 1999), D. melanogaster (Rogina and
Helfand, 2004), and C. elegans (Tissenbaum and Gua-
rente, 2001) extend life span, suggesting that Sir2
genes are conserved regulators of the aging process.
In mammals, there are seven Sir2 orthologs SIRT1–7
(Frye, 2000). SIRT1 has been implicated in diverse met-
abolic functions, including adipogenesis (Picard et al.,
2004), myogenesis (Fulco et al., 2003), and apoptosis
(Brunet et al., 2004; Cohen et al., 2004; Luo et al., 2001;
Motta et al., 2004; Vaziri et al., 2001).
In C. elegans, life span extension conferred by in-
creased dosage of sir-2.1 requires the forkhead tran-
scription factor daf-16, a member of the C. elegans
insulin/IGF signaling pathway (Tissenbaum and Guar-
ente, 2001). Signaling through this pathway begins at
the insulin receptor DAF-2 and continues through a
series of kinases that ultimately phosphorylate DAF-16,
resulting in its cytoplasmic retention (Kenyon, 2005).
Downregulation of this pathway, by mutations in daf-2
for example, results in nuclear localization of DAF-16
and the induction of genes that confer longevity (re-
viewed in Braeckman et al., 2001).
Small molecules that alter SIR2 enzymatic activity
have been identified (reviewed in Porcu and Chiarugi,
2005). Nicotinamide (Bitterman et al., 2002), a product
of the Sir2 deacetylase reaction, and NADH (Lin et al.,
2004; Schmidt et al., 2004) are potent inhibitors of SIR2
deacetylase activity in vivo. Resveratrol (3, 4#, 5-trihy-
droxystilbene), a plant-derived polyphenolic com-
pound, is among a number of small molecules that
were initially shown to activate the catalytic activity of
mammalian ortholog SIRT1 and yeast Sir2p (Howitz et
al., 2003). Resveratrol has been observed to have thera-
peutic benefits, including cancer prevention (Aggarwal
et al., 2004), cardio protection (Hung et al., 2000; Sato
et al., 2002), and antifungal effects (reviewed in Pervaiz,
2003). Recent studies suggest that the activation of
Sir2 by resveratrol may result from the fluorescently
tagged substrate used in the in vitro assay for Sir2
deacteylase activity (Borra et al., 2005; Kaeberlein et
al., 2005). Still, there is significant in vivo evidence to
suggest that resveratrol extends life span in a Sir2-
dependent manner (Howitz et al., 2003; Wood et al.,
2004).
In this study, we examine the mechanism of life span
extension conferred by resveratrol in C. elegans. We
find that life span extension by this compound is de-
pendent upon sir-2.1, yet is independent of daf-16,
identifying a longevity pathway that is mediated by sir-
2.1 but is independent of the insulin/IGF pathway. Ge-
nome-wide microarrays demonstrate that resveratrol
upregulates a family of stress response genes encoding
prion-like glutamine/asparagine-rich proteins that are
thought to aid protein folding in the endoplasmic reticu-
lum (ER) (Urano et al., 2002). At least one of these ER
stress genes, abu-11, is necessary and sufficient for the
longevity conferred by resveratrol. Expression of abu-
Developmental Cell
60611, as well as several other members of this gene fam-
ily, is repressed by sir-2.1. This implies that resveratrol
inhibits SIR-2.1 action on these genes, challenging
earlier reports that resveratrol is an activator of Sir2 ca-
talytic activity. Our findings identify these ER stress
proteins as possible determinants of organismal life
span, and they show that their activation is the likely
mechanism by which resveratrol extends life span in
C. elegans.
Results
Life Span Extension in C. elegans by Resveratrol
Requires sir-2.1, but Not daf-16
Resveratrol extended C. elegans life span in a dosage-
dependent manner, increasing both the mean and max-
imum life span of wild-type worms (Figure 1A). A nearly
18% increase in mean life span was obtained with 1
mM resveratrol. We next determined whether sir-2.1
was required for life span extension by resveratrol, as
it is in yeast and Drosophila (Wood et al., 2004). Two
independent sir-2.1 mutant strains were assayed for life
span in the presence of varying concentrations of
resveratrol. While wild-type worms demonstrated a sig-
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pFigure 1. Resveratrol Extends C. elegans Life Span by a sir-2.1-Dependent and daf-16-Independent Mechanism
(A) Resveratrol extends wild-type life span in a dosage-dependent manner. 0 M control (m = 21.4, M = 32, n = 123); 100 M (m = 23.4, M =
32, n = 114, p < 0.0001, 9.3%); 500 M (m = 24.4, M = 34, n = 113, p < 0.0001, 14.0%); 1000 M (m = 25.2, M = 34, n = 124, p < 0.0001, 17.8%).
(B) Resveratrol does not extend life span of the LG231 sir-2.1(ok434) deletion mutant. 0 M (m = 17.3, M = 24, n = 80); 100 M (m = 18.1, M = 26,
n = 85, p = 0.0500 [ns], 4.6%); 500 M (m = 17.9, M = 26, n = 71, p = 0.0857 [ns], 3.5%); 1000 M (m = 18.2, M = 24, n = 81, p = 0.1695 [ns], 5.2%).
(C) Resveratrol does not extend life span of the NL4251 sir-2.1::pk1640 transposon insertion mutant. 0 M (m = 16.8, M = 26, n = 55); 100 M
(m = 16.5, M = 30, n = 116, p = 0.3208 [ns], −1.8%); 500 M (m = 16.9, M = 30, n = 90, p = 0.8441 [ns], 0.6%); 1000 M (m = 18.2, M = 30, n =
81, p = 0.0711 [ns], 8.3%).
(D) Resveratrol extends life span of the GR1307 daf-16(mgDf50) mutant. 0 M (m = 14.1, M = 20, n = 120); 100 M (m = 15.5, M = 26, n =
113, p < 0.0001, 9.9%); 500 M (m = 17.4, M = 26, n = 133, p < 0.0001, 23.4%); 1000 M (m = 18.1, M = 28, n = 106, p < 0.0001, 28.4%).
C. elegans life span assays were performed on NGM + DMSO + FUdR plates containing resveratrol at the specified concentrations. Mean
day of life span (m), maximum day of life span (M), number of animals (n), log-rank observed significance levels (p), and percentage difference
in mean relative to no resveratrol control are reported for each assay. All life spans were repeated and showed similar effects. Ns, not signif-
icant.nificant increase in life span in the presence of 1 mMesveratrol (Figure 1A), neither sir-2.1 mutant strain
howed a significant change in life span at any of the
oncentrations of resveratrol tested (Figures 1B and
C), demonstrating that the effect of resveratrol on
orm life span is completely dependent on sir-2.1.
The life span extension by a sir-2.1 transgene is fully
ependent upon the insulin/IGF pathway and its fork-
ead transcription factor, daf-16 (Tissenbaum and Gua-
ente, 2001). Given that life span extension by resvera-
rol is dependent upon sir-2.1, we postulated that
esveratrol worked by phenocopying the mechanism of
ife span extension in sir-2.1 transgenic animals. We
ested this idea by determining whether life span exten-
ion by resveratrol was dependent upon daf-16. Sur-
risingly, when daf-16 mutant animals were assayed for
ife span on media containing resveratrol, a robust in-
rease in life span was noted in a dosage-dependent
anner (Figure 1D). At the highest concentration, daf-
6 worms lived an average of 28.4% longer than non-
reated worms. These results demonstrate that the
echanism of life span extension by resveratrol differs
rom that of sir-2.1 overexpression, thus identifying a
eparate pathway of life span regulation, which is de-
endent upon sir-2.1 but independent of daf-16.
In order to determine whether resveratrol-induced life
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2.1, as it is in wild-type worms, we tested whether
resveratrol could extend the life span of sir-2.1; daf-
16 double mutants. As shown in Figure 2A, resveratrol
significantly extended the life span of daf-16 mutant
animals (19.6%) relative to untreated animals, yet it did
not extend either the sir-2.1 single mutant or the sir-2.1;
daf-16 double mutant. This result demonstrates that
the life span extension by resveratrol in both wild-typeFigure 2. Resveratrol Treatment Extends C. elegans Life Span by a
Different Mechanism from that of sir-2.1 Overexpression
Open symbols are control animals; closed symbols are worms
treated with 500 M resveratrol. Reported p values are relative to
the 0 M control for each strain.
(A) Loss of sir-2.1 abolishes resveratrol-induced life span extension
of the short-lived daf-16 mutant. GR1307 daf-16(mgDf50): 0 M
(m = 13.8, M = 20, n = 78); 500 M (m = 16.5, M =20, n = 78, p <
0.0001, 19.6%). NL4251 sir-2.1(pk1460::Tc1): 0 M (m = 16.1, M =
22, n = 71); 500 M (m = 15.7, M = 22, n = 78, p = 0.2543 [ns],
−0.2%). LG267 daf-16(mgDf50); sir-2.1(pk1460::Tc1): 0 M (m =
14.4, M = 20, n = 73); 500 M (m = 14.4, M = 20, n = 77, p = 0.5460
[ns], 0.0%). Similar results were obtained with LG265 sir-2.1(ok434);
daf-16(mgDf50) mutants and their respective controls (data not
shown).
(B) Resveratrol extends life span of the sir-2.1 transgenic worms
even in the absence of daf-16. GR1307 daf-16(mgDf50): 0 M (m =
14.1, M = 20, n = 120); 500 M (m = 18.1, M = 28, n = 106, p <
0.0001, 28.4%). NL3908 pkIs1641(unc-119[+]): 0 M (m = 21.4, M =
32, n = 123); 500 M (m = 24.4, M = 34, n = 113, p < 0.0001, 14.0%).
NL3909 pkIs1642(unc-119[+] sir-2.1[+]): 0 M (m = 27.0, M = 46, n =
131); 500 M (m = 37.5, M = 58, n = 137, p < 0.0001, 38.9%). LG248
daf-16(mgDf50); pkIs1642(unc-119[+] sir-2.1[+]): 0 M (m = 14.2,
M = 20, n = 118); 500 M (m = 19.5, M = 26, n = 110, p < 0.0001,
37.3%). Life span assays in (B) were performed once.and daf-16 backgrounds is mediated via sir-2.1, andthis finding strengthens the surmise that sir-2.1 can
participate in a pathway of life span regulation indepen-
dent of daf-16.
We also examined the effect of resveratrol on sir-2.1
transgenic strains. As shown in Figure 2B, sir-2.1 trans-
genic animals carrying an integrated low-copy array
have a robustly extended life span. Moreover, resvera-
trol treatment of these already long-lived animals fur-
ther increases the mean life span by 39%, extending
the maximum age to nearly 2 months. Life span exten-
sion was also seen in resveratrol-treated daf-16 and
wild-type animals, as expected. In the absence of
resveratrol, loss of daf-16 abolished the life span exten-
sion of low-copy sir-2.1 overexpression, reducing the
life span to the level of the daf-16 mutant (Figure 2B). In
the presence of resveratrol, however, the daf-16 mutant
carrying the sir-2.1 transgene lived an average of 37%
longer. The life span effect of resveratrol is additive with
that due to overexpression of sir-2.1, consistent with
the idea that resveratrol and overexpression of sir-2.1
extend life span by distinct pathways.
Genome-Wide Transcriptional Profiling
of Resveratrol-Treated C. elegans
To identify genetic components that may contribute to
resveratrol-mediated life span extension, we carried
out genome-wide microarray analysis, comparing the
transcriptional profiles of worms grown in the presence
and absence of resveratrol. Since resveratrol treatment
resulted in life span extension in both wild-type and
daf-16 mutant worms, microarray analysis was per-
formed with both strains independently. Microarray
data were analyzed for genes that were regulated by
resveratrol (p < 0.01) in either wild-type or daf-16
strains (Table S1; see the Supplemental Data available
with this article online). The most highly induced coor-
dinately regulated gene, cyp-13A6, encoding a cyto-
chrome P450 protein, was upregulated 23-fold in wild-
type and 8-fold in daf-16 mutant worms. Cytochrome
P450 proteins have been shown to be involved in the
metabolism of resveratrol (Piver et al., 2004). Further-
more, resveratrol has been shown to be an enzymatic
inhibitor of some cytochrome P450 proteins (Piver et
al., 2001), and it affects the expression of P450 proteins
in cancer cells (Liu et al., 2004).
Strikingly, a novel family of genes comprising pqn
(prion-like Q/N proteins) and abu (activated in blocked
unfolded protein response, see below) genes was also
induced by treatment with resveratrol (Table 1). PQN
and ABU proteins are members of a prion-like gluta-
mine/asparagine-rich protein family. Many of the abu/
pqn genes listed in Table 1 are also coregulated in other
experimental and developmental conditions, as evi-
denced by the fact that they are clustered together
in the relatively small and distinct mountain 29 of the
C. elegans topographical expression map (Kim et al.,
2001).
The abu class of genes, which are a subset of the
pqn gene family, have been implicated in a pathway of
protein folding in the ER that functions in parallel with
the canonical unfolded protein response (UPR) path-
way (see Discussion). Eleven abu genes are induced in
response to ER stress caused by the protein glycosyla-
tion inhibitor tunicamycin in worms in which the UPR
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608Table 1. C. elegans pqn-Related Genes Regulated by Resveratrol Treatment and SIR-2.1 Overexpression
Protein Description
Induction in Induction in Repression in
Gene Wild-Type by daf-16 by SIR-2.1 DUF 1096 DUF 139 Signal Transmembrane
ORF Name Name Resveratrol Resveratrol Overexpressor (+/−) (#) Peptide Domain Mountain
Y105C5A.5 pqn-78 1.97 ± 0.77 2.66 ± 0.27 −1.27 ± 0.47 + 10 + + 16
Y105C5A.3 pqn-76 2.05 ± 0.79 2.61 ± 0.32 −2.01 ± 0.50 + 10 + + 29
F19G12.7 pqn-30/ 1.79 ± 0.62 2.44 ± 0.38 −1.29 ± 0.39 + 19 + + 29
abu-2
Y73F8A.9 pqn-91 1.86 ± 0.81 2.42 ± 0.38 −1.41 ± 0.27 + 14 + + 29
Y105C5A.4 pqn-77/ 1.98 ± 0.79 2.42 ± 0.29 −0.90 ± 0.26 + 10 + + 29
abu-5
F10F2.9 pqn-29 ns 2.41 ± 0.18 −0.41 ± 0.12 − — + − NA
F31A3.1 abu-3 1.94 ± 0.59 2.35 ± 0.39 −1.02 ± 0.39 − 9 + − 9
M02G9.2 M02G9.2 ns 2.22 ± 0.37 ns + 8 + + NA
F07H5.8 F07H5.8 ns 2.15 ± 0.43 −1.85 ± 0.34 − 22 − − 29
ZK1067.7 pqn-95 ns 1.97 ± 0.11 ns − 8 + − 14
W02A2.3 pqn-74 ns 1.82 ± 0.29 −1.47 ± 0.22 − — + − NA
F35D11.2 pqn-35 ns 1.82 ± 0.15 −0.68 ± 0.13 − — − − 26
T01D1.6 pqn-61/ 1.60 ± 0.66 1.78 ± 0.30 ns + 10 + − 29
abu-11
T22B2.6 T22B2.6 ns 1.66 ± 0.10 ns − 1 + − 29
C03A7.4 pqn-5 2.05 ± 0.57 ns −0.84 ± 0.28 + 9 + − 29
R09B5.5 pqn-54 2.07 ± 0.54 1.54 ± 0.40 −1.02 ± 0.27 + 9 + − 29
C03A7.7 pqn-6/ 2.23 ± 0.40 ns −1.28 ± 0.37 + 9 + − 29
abu-6
C03A7.8 pqn-7/ 2.14 ± 0.50 ns −1.12 ± 0.26 + 9 + − 29
abu-7
C03A7.14 pqn-4/ 2.14 ± 0.47 ns −1.12 ± 0.37 + 9 + − 29
abu-8
Shown are the mean ± SEM of base2 log-fold changes in wild-type (n = 4, p < 0.05) and daf-16 (n = 4, p < 0.001) strains after treatment with
resveratrol and in the SIR-2.1 low-copy overexpression strain NL3909 (n = 4, p < 0.014) relative to control NL3908 for pqn (prion-like glutamine
[Q]/asparagines [N]), abu (activated in blocked unfolded protein response), and other pqn/abu-related genes (containing domain of unknown
function [DUF] 1096 and/or DUF139 domains). abu genes are categorized as ER stress response genes based on experimental evidence (Urano
et al., 2002). pqn genes encoding prion-like Q/N-rich domain-bearing proteins are predicted based on the DIANA prediction algorithm (Michelitsch
and Weissman, 2000). NH2-terminal Q-rich domains are annotated as DUF1096 (Interpro accession IPR009475), and C-X3-C-X3-C cysteine-rich
repeats are annotated as DUF139 (Interpro accession IPR003341) in WormBase. The presence of a signal peptide sequence was determined by
using the SignalP 3.0 program (www.cbs.dtu.dk/services/SignalP [Bendtsen et al., 2004]). The presence of transmembrane domains was
determined with the PHD program (www.predictprotein.org [Rost, 1996]). The location of genes within the C. elegans global expression mountain
system (Kim et al., 2001) is also annotated when available. ns, not significant; NA, not available.pathway is compromised (Urano et al., 2002). Se-
quences of some of the PQN and ABU proteins demon-
strating their similarity are shown in Figure S1 (see the
Supplemental Data available with this article online).
ABU proteins contain amino-terminal ER signal se-
quences necessary for translocation across the ER
membrane (Table 1). ABU1–9 contain putative trans-
membrane domains and short cytoplasmic tails, while
ABU-10 and ABU-11 appear to be luminal. Three other
genes found to be induced by resveratrol, M02G9.2,
F07H5.8, and T22B2.6, are not classified as pqn or abu
genes, but they are included in Table 1 because of sim-
ilarities of their domain architecture to pqn genes.
F07H5.8 and T22B2.6 are also coregulated with pqn
genes in mountain 29.
As a validation of the microarray results, RT-PCR
analysis was performed on total RNA isolated from
wild-type and daf-16 worms grown in the presence or
absence of resveratrol. cyp-13A6 transcript is upregu-
lated by resveratrol, as demonstrated by the fact that
its PCR product was generated at higher dilutions of
cDNA from resveratrol-treated worms compared to un-
treated in both wild-type (Figure 3A, lane 7 versus lane
1) and daf-16 samples (Figure 3B, lane 6 versus lane 1).
act-1 (actin) served as a control for equivalency of input
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scDNA in these PCR reactions. The RT-PCR assay alsoonfirmed an increase in abu-11 RNA in the resveratrol-
reated worms (Figure 3A, lane 7 and Figure 3B, lane 6)
ompared to untreated worms (Figure 3A, lane 2 and
igure 3B, lane 1), but the effect was not as strong as
or cyp-13A6, consistent with the array data.
To test more definitively whether resveratrol induced
bu-11 RNA, Northern analysis was performed on total
NA isolated from two independent sets of samples of
ild-type (Figure 3C) and daf-16 (Figure 3D) worms
rown in the presence or absence of resveratrol. In
hese blots probed with abu-11-specific probes, tran-
cripts were 3- to 4-fold higher in total RNA isolated
rom resveratrol-treated wild-type (Figure 3C) and daf-
6 (Figure 3D) worms relative to control, untreated sam-
les. Total RNA samples for Northern analysis were ver-
fied for equal loading by hybridization to act-1 (actin)
robe (Figure 3C) and visualization of 28s and 18s rRNA
y ethidium bromide staining (Figure 3D).
ife Span Extension by Resveratrol Treatment Is
ependent upon the ER Stress Gene abu-11
e hypothesized that the pqn/abu family of genes in-
uced by resveratrol and by ER stress could be media-
ors of life span extension by resveratrol. Seven ER
tress genes, pqn-76, pqn-78, abu-2, pqn-91, abu-5,abu-11, and pqn-54, upregulated in both wild-type and
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(A–D) Synchronized wild-type and GR1307 daf-16(mgDf50) L1-stage worms were grown in the absence (C) or presence (R) of 1000 M
resveratrol to young adults. Purified total RNA was isolated and used for (A and B) RT-PCR or (C and D) Northern analysis to detect cyp-
13A6, abu-11, and act-1 (actin) transcripts. RT-PCR products were run on agarose gels stained with ethidium bromide. PCR products in (A)
and (B), lanes 1–4 and 5–8, are generated from stepwise 10-fold serially diluted cDNA by using gene-specific primers. Northern gels were
prepared with 10 g total RNA from two independent worm preparations, transferred to membranes, and blotted with gene-specific radioac-
tive probes for abu-11 and act-1. Ethidium bromide staining of agarose gel shows 28s and 18s rRNA samples as loading controls in (D).daf-16 strains (Table 1), were chosen for functional
analysis. Bacterial feeding strains that induce gene-
specific RNAi were utilized to determine if any of the
selected ER stress genes, when downregulated, could
abolish resveratrol-mediated life span extension in the
daf-16 strain. Seven sets of RNAi life span assays were
performed, including one set utilizing the control bacte-
rial strain MV175, which contained vector alone.
Resveratrol treatment of daf-16 worms on control
RNAi bacteria caused a robust 23% extension in mean
life span (Figure 4, all panels). Although RNAi of pqn-
76/78 (Figure 4A), pqn-91 (Figure 4B), and pqn-54 (Fig-
ure 4C) shortened life span in the absence of resvera-
trol, they still allowed for significant (p < 0.0001) life
span extension by resveratrol. RNAi of abu-11, how-
ever, completely abolished resveratrol-mediated life
span extension in both wild-type (Figure S2A) and daf-
16 (Figure 4D; Figure S2B) worms, while it shortened
the life span in the absence of the compound. RNAi of
abu-2 (Figure 4E) and abu-5 (Figure 4F) showed no ef-
fect on the life span of untreated worms, but abu-5
RNAi partially blunted the extension by resveratrol.
These findings show that abu-11, and to a lesser extent
abu-5, are necessary for resveratrol to extend life span.
C. elegans sir-2.1 Regulates Expression
of ER Stress Genes
Since resveratrol has been reported to be a Sir2 activa-
tor, we hypothesized that SIR-2.1 might be a positive
transcriptional regulator of ER stress genes and is acti-
vated by resveratrol. By such a model, we expected to
observe reduced transcription of these genes in sir-2.1
mutants. Total RNA isolated from wild-type and sir-2.1
mutant worms was analyzed by Northern analysis prob-
ing for abu-11 transcript. Surprisingly, in sir-2.1(ok434)mutants, abu-11 transcription was 15- to 20-fold higher
relative to wild-type worms (Figure 5A), indicating that
SIR-2.1 is a repressor of this gene. A similar increase
was evident in the pk1460::Tc1 insertion mutant of sir-
2.1 (data not shown). Furthermore, the elevated level
of abu-11 transcript in the sir-2.1 mutant background
remained unchanged with resveratrol treatment (Figure
5A). Northern probes were also designed to examine
the transcript levels of other ER stress-related genes
induced by resveratrol in the microarray. Similar to in-
duction of abu-11, transcripts for abu-7/8 and pqn-5/6
were highly induced in sir-2.1 mutant worms (Figure
5B). Transcripts for pqn-76/77/78/79 (Figure 5C) and
abu-2 (Figure 5D) were also found to be elevated (ca.
2-fold) in the sir-2.1 mutant background.
Although these data suggested that SIR-2.1 is a re-
pressor of the pqn genes, it seemed possible that the
mutant showed induction because of some secondary
effect, for example, elevated endogenous stress in the
ER. To test in a different way whether SIR-2.1 was a
repressor of the pqn genes, we assessed whether over-
expression would reduce transcript levels below those
in a wild-type control. Microarray analysis of gene ex-
pression in the sir-2.1 low-copy transgenic strain
NL3909 relative to its control NL3908 (Table S1) indeed
confirmed that the majority of pqn/abu genes induced
by resveratrol are repressed below control levels by
overexpression of SIR-2.1 (Table 1).
C. elegans abu-11 Modulates Life Span
If resveratrol extends life span by upregulating ER
stress proteins, then increased expression of one or
more of these proteins by transgenes per se may trig-
ger a longer life span. To test this idea, we created
transgenic animals containing multicopy abu-11 ex-
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(A–F) Survival curves of GR1307 daf-16(mgDf50) worms fed E. coli containing either vector L4440 or gene-specific dsRNA trigger-producing
vectors. Life spans were performed on NGM + Ap + Tc media with (open symbol) and without (closed symbol) 500 M resveratrol. p values
and percentage difference in life span are relative to untreated worms for each gene tested. (A–F) vector: 0 M (m = 15.6, M = 20, n = 83);
500 M (m = 19.2, M = 24, n = 78, p < 0.0001, 23.1%). (A) pqn-76/78 RNAi: 0 M (m = 14.0, M = 18, n = 77); 500 M (m = 16.0, M = 22, n =
103, p < 0.0001, 14.3%). (B) pqn-91 RNAi: 0 M (m = 14.7, M = 18, n = 76); 500 M (m = 16.8, M = 22, n = 80, p < 0.0001, 14.3%). (C) pqn-54
RNAi: 0 M (m = 11.6, M = 18, n = 78); 500 M (m = 15.5, M = 22, n = 81, p < 0.0001, 33.6%). (D) abu-11 RNAi: 0 M (m = 14.1, M = 20, n =
74); 500 M (m = 14.9, M = 20, n = 72, p = 0.100 [ns], 5.7%). (E) abu-2 RNAi: 0 M (m = 16.0, M = 24 n = 75); 500 M (m = 19.1, M = 24, n =
80, p < 0.0001, 19.4%). (F) abu-5 RNAi: 0 M (m = 16.1, M = 22, n = 82); 500 M (m = 17.4, M = 24, n = 78, p = 0.0015, 8.1%). Life span
assays were performed once.trachromasomal arrays to overexpress ABU-11. Wild-
type worms were coinjected with plasmid pABU11 con-
taining abu-11 under its endogenous promoter, and
pRF4 containing the dominant transformation marker
rol-6 (su1006). Six independently derived lines of
worms that stably transmitted their arrays were iso-
lated. Lines with the rol-6 marker alone were used as
control. abu-11 transgenic animals were assayed for
life span along with rol-6 control worms (Figure 5E). All
six lines of abu-11 transgenic animals demonstrated
significant extension of life span relative to rol-
6(geEx106) control; mean life span extension ranged
from 9% to 28%. Transgenic roller worms from each of
t
o
m
g
s
g
p
p
D
I
ehe transformed lines showed an increased expression
f abu-11 transcript relative to control worms as deter-
ined by Northern analysis (Figure 5F). Moreover, a
ood correlation between the level of abu-11 expres-
ion and life span extension was observed; lines
eEx109–111 with high levels of abu-11 expression dis-
layed longer life spans than the more moderately ex-
ressing lines geEx102–104.
iscussion
n this study, we have analyzed the role of resveratrol in
xtending the life span of C. elegans and demonstrated
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611Figure 5. sir-2.1 Negatively Regulates abu/pqn Gene Expression, and Overexpression of abu-11 Extends Life Span
(A–D) Total RNA isolated from wild-type and LG231 sir-2.1(ok434) mutant worms were subjected to Northern analysis. Northern blots were
hybridized with probes to detect levels of (A) abu-11, (B) abu-7/8 and pqn-5/abu-6, (C) pqn-76/77/78/79, (D) abu-2, and (A–D) act-1 transcripts.
pqn-76, pqn-77, pqn-78, and pqn-79 mRNA are 99.5% identical and therefore cannot be differentiated from one another with the probe
utilized. abu-7 and abu-8 have 93.4% mRNA sequence identity, and abu-6 and pqn-5 are 98.3% identical; while the four transcripts hybridize
with a common probe, the two sets can be distinguished based on size difference.
(E) Survival curves of six independently derived abu-11 extrachromosomal array lines (geEx102–104 and geEx109–111). LG263 geEx106,
containing an array of the rol-6(su1006) marker alone, was used as control. LG263 geEx106 (m = 16.6, M = 22, n = 78), LG259 geEx102 (m =
18.2, M = 28, n = 77, p = 0.0002, 9.6%), LG260 geEx103 (m = 18.1, M = 26, n = 94, p < 0.0001, 9.0%), LG261 geEx104 (m = 18.3, M = 28, n =
81, p < 0.0001, 10.2%), LG271 geEx109 (m = 21.1, M = 28, n = 85, p < 0.0001, 27.7%), LG272 geEx110 (m = 20.1, M = 28, n = 83, p < 0.0001,
21.1%), LG273 geEx111 (m = 20.3, M = 26, n = 72, p < 0.0001, 22.9%). Wild-type worms (not shown) had life spans similar (m = 16.4, M = 22,
n = 90, p = 0.890 [ns]) to LG263. p values and percentage change in mean are relative to LG263 geEx106. Life span assays were performed
twice with similar results.
(F) Total RNA isolated from transgenic (roller) worms from the six lines (geEx102–104 and geEx109–111) of abu-11 transgenic animals and
their respective control (geEx106) were probed to detect abu-11 and act-1 transcript levels by Northern analysis.induction of a set of genes previously shown to be in-
volved in ER stress (Urano et al., 2002). These genes
are also regulated by the C. elegans ortholog of Sir2,
sir-2.1 (see below). Previous work (Tissenbaum and Gu-
arente, 2001) and experiments reported here show that
extension of life span by increasing the sir-2.1 gene
dosage requires the forkhead transcription factor DAF-
16, a critical component of the insulin/IGF signaling
pathway. However, the roles of sir-2.1 and resveratrol in
the ER stress pathway can be separated genetically
from the insulin/IGF pathway by virtue of the fact that
extension of life span by resveratrol, while dependent
upon sir-2.1, is completely independent of daf-16. Our
findings provide a possible link between ER homeosta-
sis and life span, and they show that this pathway is
regulated by sir-2.1 and resveratrol.
Our findings contrast with the recent report that
resveratrol reduced poly-glutamine cytotoxicity in C. ele-
gans in a manner dependent on both sir-2.1 and daf-16
(Parker et al., 2005). The poly-glutamine-related toxicity
noted in this study likely occurs in the nucleus and cy-
toplasm, and it implicates a sir-2.1 activity that func-
tions through the insulin/IGF pathway. It is interesting
to note that the longevity induced by resveratrol may
not relate to damage control in the nucleus or cyto-
plasm, but rather to stress response in the ER.Resveratrol Induces a Longevity Pathway
Involving Putative ER Stress Proteins
Comparative analysis of microarray expression profiles
revealed that resveratrol treatment of wild-type and
short-lived daf-16 strains significantly induced many
members of the large C. elegans pqn gene family that
encode prion-like Q/N-rich domain-bearing proteins
(Michelitsch and Weissman, 2000). Among the pqn
genes induced by resveratrol, a subset, renamed abu
for activated in blocked unfolded protein response, is
also induced by the ER stress compound tunicamycin,
an inhibitor of ER protein glycosylation (Urano et al.,
2002). This induction is manifest in strains in which the
canonical unfolded protein response (UPR) pathway is
disabled. Most members of the PQN/ABU family found
induced by resveratrol bear sequence hallmarks of ER
proteins (Table 1). The pqn genes may respond to a
particular kind of ER stress or may serve as a backup
to the UPR.
Functional studies also imply that ABU proteins func-
tion in parallel with the UPR pathway. The UPR pathway
is regulated by XBP-1 (X-box binding protein), an ER
stress-responsive transcription factor that activates
many UPR-specific genes, including the ER chaperone
BiP (hsp-4), protein disulfide isomerases, and proteins
involved in the ER-associated protein degradation
Developmental Cell
612pathway (Harding et al., 2002; Ma and Hendershot,
2002; Schroder and Kaufman, 2005). Inactivation of
abu-1 by RNAi slightly decreases the survival of wild-
type worms and is associated with the accumulation of
misfolded proteins in the ER in certain genetic back-
grounds (Urano et al., 2002). Moreover, RNAi of abu-1
substantially decreases the survival of xbp-1 mutant
worms when treated with cadmium, an ER stressor (Ur-
ano et al., 2002). The synthetic effect of inactivating
abu-1 and xbp-1 suggests that the abu genes and the
genes controlled by xbp-1 are in parallel pathways reg-
ulating ER stress. These two pathways apparently in-
teract, because abu-1 RNAi also induces BiP expres-
sion, and this induction requires xbp-1 (Urano et al.,
2002).
Regulation of pqn/abu Genes by sir-2.1
and Resveratrol
Is the induction of pqn genes the mechanism by which
resveratrol extends life span in C. elegans? RNAi of
abu-5 partially reduced resveratrol-mediated life span
extension, and RNAi of abu-11 fully abolished this ef-
fect in both wild-type and daf-16 mutant backgrounds
(Figure 4D and Figure S2). Moreover, overexpression of
abu-11 in transgenic worms extended their life span in
a dosage-dependent manner (Figure 5E). These find-
ings indicate that induction of ABU proteins is an
essential part of the mechanism by which life span is
extended by resveratrol. In agreement with the microar-
ray data, abu-11 is transcriptionally induced after
resveratrol treatment, as determined by Northern and
RT-PCR analyses (Figure 3). Our findings suggest that
ER stress during aging may limit nematode life span
and that ER stress genes are longevity determinants in
C. elegans.
Given that resveratrol has been reported to activate
Sir2 deacetylases and loss of sir-2.1 or abu-11 each
abolished the effect of resveratrol on life span, we first
reasoned that SIR-2.1 must be a positive regulator of
the abu genes. We were surprised to find that, in fact,
the opposite is the case: expression of abu-11 and sev-
eral other pqn/abu family members is actually much
higher in sir-2.1 mutant animals. These findings sug-
gested that SIR-2.1 is a repressor of pqn genes. More-
over, the fact that worms overexpressing sir-2.1 repress
basal expression of many pqn/abu genes further de-
monstrates that sir-2.1 is a transcriptional repressor of
this gene family.
It seems curious that sir-2.1 mutants that have high
levels of pqn gene expression actually display a short
life span. One possible explanation is that sir-2.1 has at
least one other function, in addition to regulating the
insulin/IGF pathway and pqn genes, that is required for
long life. Alternatively, highly elevated expression of
multiple pqn family genes, caused by loss of sir-2.1
function, may be detrimental to life span. If this were
the case, then setting optimum levels of expression of
these genes may be critical to having beneficial effects
on life span.
How Does Resveratrol Induce pqn/abu Genes?
Given that SIR-2.1 is a repressor of pqn/abu genes, the
induction of these genes by resveratrol is surprising,
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tecause this compound has been reported to increase
he catalytic activity of Sir2 proteins (Howitz et al.,
003). Resveratrol instead appears to inhibit SIR-2.1
ctivity with respect to pqn/abu gene regulation. It may
ppear that resveratrol indirectly induces the ER stress
enes, for example, by creating a higher level of cellular
tress. However, the genes induced by resveratrol do
ot evince a broad induction of stress response genes.
Venn diagram comparing genes induced by resverat-
ol to those induced by heat shock, oxidative stress, or
thanol stress treatments illustrates the complete lack
f overlap between resveratrol-induced genes and
enes induced by these other cellular stressors (Figure
A). Also, resveratrol does not appear to generate
road stress in the ER, since it does not induce canoni-
al UPR pathway genes such as xbp-1, hsp-4, sel-1,
nd pdi-1 (Table S1) as other ER stress agents do (Ur-
no et al., 2002).
Nevertheless, there is a substantial overlap between
esveratrol-induced genes and genes induced by tuni-
amycin in worms lacking the UPR (Figure 6A), sug-
esting a more specific mechanism of activation of
hese ER stress genes by resveratrol. We suspect that
esveratrol does act directly on SIR-2.1, but not as an
ctivator of the catalytic activity of the protein. Rather,
esveratrol may bind to Sir2 proteins and exert unpre-
ictable effects on Sir2 activity. In C. elegans, resvera-
rol inhibits SIR-2.1 activity with respect to pqn/abu
enes, but it must not inhibit SIR-2.1 in the insulin/IGF
athway, since it augments the life-extending effect of
verexpressed SIR-2.1. By binding to Sir2 proteins,
esveratrol may change their affinity for substrate pro-
eins, potentially increasing, reducing, or having no ef-
ect, depending on the specific Sir2-substrate protein
nteraction. This would explain how resveratrol could
xert substrate-specific activities in vitro (Borra et al.,
005; Kaeberlein et al., 2005) and have differential af-
ects on different pathways in C. elegans.
onclusions
ur findings identify a family of putative ER stress re-
ponse proteins as positive determinants of life span in
. elegans, thereby implicating unfolded proteins in the
R in normal aging. These genes are regulated by the
ir2 ortholog sir-2.1. Resveratrol activates these genes
o extend life span by inhibiting the repressive activity
f sir-2.1. Since sir-2.1 also functions independently to
odulate life span via the insulin/IGF pathway, this sir-
uin sits astride multiple pathways that influence life
pan by different mechanisms (Figure 6B).
xperimental Procedures
hemicals
mpicillin (Ap), Tetracycline (Tc), Isopropyl β-D-thiogalactopyrano-
ide (ITPG), 5-Fluorodeoxyuridine (FUdR), and Dimethylsulfoxide
DMSO) were utilized at final concentrations of 100 g/ml, 15 g/
l, 1 mM, 12.5 g/ml, and 2%, respectively. Resveratrol (Sigma;
t. Louis, MO) was dissolved in ethanol at a concentration of 50
g/ml and was stored at −20°C.
edia and Strains
tandard nematode growth medium (NGM) (Brenner, 1974) seeded
ith E. coli OP50 (Brenner, 1974) was used for C. elegans propaga-
ion at 20°C. Growth of worms for RNA isolation was done on NGM
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613Figure 6. Resveratrol Extends C. elegans Life Span by Inducing ER
Stress Response Genes
(A) Venn diagram illustrating the overlap between C. elegans genes
induced by resveratrol and those induced by various stress treat-
ments. Included are genes induced by resveratrol treatment of
wild-type worms (mean log2-fold difference > 1.5, p < 0.05), tuni-
camycin treatment of the UPR-deficient xbp-1 mutant strain (Urano
et al., 2002), paraquat treatment of fer-15 animals (mean log2-fold
difference > 1.5, p < 0.001 [one-way ANOVA], M. Jiang and S. Kim
unpublished results), ethanol treatment of wild-type worms (Kwon
et al., 2004), and heat shock of wild-type worms (GuhaThakurta et
al., 2002). A list of the overlapping genes can be found in Table S3.
(B) C. elegans sir-2.1 is involved in at least two different pathways
that regulate nematode life span. In the first, SIR-2.1 acts via DAF-
16, leading to the activation of DAF-16-responsive genes. In a sep-
arate pathway, sir-2.1 acts to repress the expression of abu-11 and
a number of other pqn family genes believed to be involved in regu-
lating protein folding within the endoplasmic reticulum. Resveratrol
evidently acts to inhibit SIR-2.1, leading to derepression of abu-11
and other abu/pqn genes, which potentially results in a heightened
level of protein folding surveillance within the ER that, in turn, ulti-
mately increases the life span of the animal.media containing 2.5 g/l yeast extract and 20 g/l agar. Resveratrol-
containing media was supplemented with DMSO. Resveratrol-con-
taining media without DMSO failed to show any substantial life
span extension, suggesting that solubility in DMSO is necessary for
drug efficacy (data not shown). Life span assays were performed in
the presence of FUdR. FUdR and DMSO were found to have no
impact on life span at the utilized concentrations.
RNAi was performed by feeding worms bacteria expressing
gene-specific double-stranded RNA (dsRNA) (Timmons et al.,
2001). Bacteria used for RNAi were grown in LB + Ap + Tc liquid
media at 37°C to OD600 = 0.4 and were induced with IPTG for 4 hr.
Five-fold concentrated cultures were spotted onto NGM + Ap + Tc +IPTG + FUdR plate media. Bacteria producing dsRNA triggers for
pqn-78, abu-2, pqn-91, abu-5, abu-11, and pqn-54 were obtained
from J. Ahringer’s (Cambridge, United Kingdom) bacterial RNA in-
terference (RNAi) library. RNAi-inducing bacterial strains are E. coli
HT115 (λDE3 F− mcrA mcrB IN[rrnD-rrnE]1 rnc14::Tn10) trans-
formants of vector L4440 containing gene-specific RNAi trigger se-
quences (Kamath et al., 2003). The control bacterial feeding strain,
MV175, is a L4440 transformant of HT115. Due to DNA sequence
similarity amongst some pqn genes (i.e., pqn-76/78, pqn-90 /91),
there is the possibility for RNAi of pqn genes other than the ones
targeted. The genomic sequence used for abu-11 RNAi, however,
does not share sufficient sequence similarity to any other C. ele-
gans gene so as to cause nonspecific interference. Northern analy-
sis of total RNA from sir-2.1 mutant animals fed either control or
abu-11 RNAi confirmed that abu-11 RNAi fully attenuates expres-
sion of the abu-11 transcript (data not shown). Sequences used for
RNAi are available on WormBase (http://www.wormbase.org).
C. elegans wild-type strain N2 (var. Bristol) and GR1307 daf-
16(mgDf50)I were obtained from the Caenorhabditis elegans
Genetics Center. Construction of strains NL4251 sir-2.1(pk1640::
Tc1)IV, LG231 sir-2.1(ok434)IV, LG267 sir-2.1(pk1640::Tc1)IV; daf-16
(mgDf50)I, NL3908 unc-119(dp38)III pkIs1641(unc-119[+]), NL3909
unc-119(dp38)III pkIs1642(unc-119[+] sir-2.1[+]), and LG248 unc-
119(dp38)III pkIs1642(unc-119[+] sir-2.1[+]); daf-16(mgDf50) will be
described in detail elsewhere. NL4251 sir-2.1(pk1640::Tc1)IV and
LG231 sir-2.1(ok434)IV were derived from progenitor strains
NL4250 mut-7(pk204)III; sir-2.1(pk1640::Tc1)IV (Van der Linden and
Plasterk, 2004) and VC199 sir-2.1(ok434)IV (from C. elegans gene
knockout consortium), respectively, following six outcrosses with
N2. Strain NL3908 contains a low-copy integrant of plasmid
pRP2510 (unc-119[+]), used as a cotransformation rescue marker
during bombardment transformations. LG259-261 geEx102–104
and LG271-273 geEx109–111 are independent isolates of the geno-
type (pRF4rol-6[su1006] + pABU11abu-11[+]) obtained by coinjec-
tion of plasmid pABU11(50 g/ml) (see below) with pRF4 (50 g/
ml) (Mello et al., 1991) into wild-type worms. pRF4 allows for domi-
nant roller selection of transgenic worms. LG263 geEx106 (rol-6
[su1006]) was obtained by injection of pRF4 (50 g/ml) alone. In all
cases, F1 roller worms were plated individually, and their broods
were scored for transmission of the transgenic array to their prog-
eny. pABU11 contains a 5373 bp PCR-amplified (Expand Long
Template PCR System; Roche, Indianapolis, IN) genomic product
with endpoints 2274 bp upstream of the first abu-11 exon and 1071
bp downstream of the last exon cloned into pCR4 (Invitrogen,
Carlsbad, CA). Ten independent pABU-11 clones were combined
for injection.
Life Spans
All life span assays were performed at 20°C, starting with L4-stage
to young adult-stage worms. Animals were monitored every other
day, and death was scored by failure to move after being prodded
with a platinum wire. To obviate the need for censor, animals that
either crawled off the plate or that died from vulval bursting were
replaced by age-matched worms from spare plates. Worm replace-
ment never exceeded 5% of the total number in any life span. Log-
rank test for comparison of survival curves was performed with
Graphpad Prism v4.0a. p values < 0.05 indicate statistically signifi-
cant differences between tested populations. Unless otherwise
stated, life span assays were repeated at least once and showed
similar trends in relative life span effect; representative Kaplan-
Meier survival curves are shown in the figures.
Microarray, Northern Analysis, RT-PCR
Four independent cultures of each strain to be analyzed by micro-
array were grown to produce gravid adults. Eggs were isolated by
alkaline hypochlorite treatment (Emmons et al., 1979) and were al-
lowed to hatch without food, accumulating as growth-arrested L1
larvae. Synchronized worms were then grown on modified NGM
media in the presence or absence of resveratrol at 20°C until the
young adult stage. Worms were harvested, frozen, and ground in
a mortar before extraction of total RNA by using TRIzol reagent
(Invitrogen). Poly(A)+ RNA used for cDNA synthesis was purified
from total RNA by using the Oligotex mRNA kit (Qiagen; Valencia,
Developmental Cell
614CA). Five micrograms of poly(A)+ RNA was used for cDNA synthe-
sis. cDNA synthesis, genome-wide microarray hybridization, and
scanning were performed as previously described (Jiang et al.,
2001). cDNA from control and experimental worms were labeled
with Cy3-UTP and Cy5-UTP, respectively. The arrays were com-
puter normalized by the default procedure in the Stanford Microar-
ray Database (http://genome-www.stanford.edu/microarray). Nor-
malized Cy5/Cy3 intensities and mean log2 Cy5/Cy3 for each gene
in each set of experiments were calculated as described in Jiang
et al. (2001). Student t distribution tests were applied independently
to data sets of mean log2 Cy5/Cy3 values to determine the prob-
ability that differences in the hybridization intensity signals be-
tween control and experimental animals were due to chance alone.
A listing of differentially regulated genes from the microarray hy-
bridizations can be found in Table S1.
Total RNA for Northern analysis was extracted from young adult
worms by using TRIzol reagent. Northern analysis of abu-11 trans-
genic worms utilized total RNA isolated from hand-picked adult
roller worms of each line tested. Northern gels and transfer to Ny-
lon membranes was performed by using the Ambion NorthernMax
kit. Membranes containing transferred RNA were UV crosslinked
and probed overnight at 42°C. Membranes were washed with 0.2×
SSC (30 mM NaCl, 3 mM Na+Citrate [pH 7.0]) + 0.1% SDS solution
three times for 20 min at 42°C and exposed to film. Radioincorpo-
rated probes were prepared with the Prime-It II (Stratagene) ran-
dom priming kit. Gel-purified templates for random priming were
synthesized by PCR utilizing primers listed in Table S2.
For RT-PCR, equal amounts of RNA (5 g) for each sample tested
were added to 1× reaction buffer, oligo-dT, and SuperScriptII re-
verse transcriptase (Invitrogen) to generate a cDNA template for
PCR as per manufacturer’s directions. Primers used for RT-PCR are
listed in Table S2. cDNA samples were serially diluted stepwise four
times in 10-fold increments, and each was used for 30 cycles of
Taq PCR amplification (92°C 20 s, 55°C 20 s, 72°C 1 min). Equal
amounts of each reaction were then analyzed on 1.5% agarose
gels stained with ethidium bromide.
Supplemental Data
Supplemental Data including microarray data files, primer se-
quences, and protein sequence alignments are available at http://
www.developmentalcell.com/cgi/content/full/9/5/605/DC1/.
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